Table 5.
Age at menarche |
Cycle length at age 18–22 |
Cycle length in adulthood |
Cycle irregularity at age 18–22 |
Cycle irregularity in adulthood |
|
---|---|---|---|---|---|
Follicular Estrogens | − | − | − | − | −2 |
Luteal Estrogens | − | + | + | − | |
Androgens | − | + | + | + | + |
Progesterone | + | +2 | |||
SHBG3 | +4 | − | − | − |
“-” indicates an inverse association and “+” indicates a positive association. Hormones for which no statistically significant associations were found are not listed in this table; including prolactin, growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding protein-3.
Became statistically significant after exclusion of anovulatory (defined by plasma progesterone <=400 ng/dL) and irregular cycles (variation from cycle to cycle of greater than +/− 7 days), and cycles with blood samples collected on an extreme luteal day (calculated by date of the first day of the next menstrual period minus luteal blood draw date).
SHBG = sex hormone binding globulin
Statistically significant when not adjusted for body mass index at age 18 and in adulthood